Postsurgical Therapeutics, Inc. is a pharmaceutical company based in Costa Mesa, CA, specializing in the development of a sustained and controlled drug delivery system using biodegradable polymers. Their innovative technology platform, which includes PLGA Microsphere and In Situ Gelling formulations, allows for the local efficacy of drugs without causing systemic side effects.
With a focus on repurposing FDA-approved drugs for new indications, Postsurgical Therapeutics currently has four different projects under development. Their CLOTT platform aims to reduce systemic toxicity while enhancing treatment efficacy for advanced, metastatic cancer patients. Additionally, the company is co-developing three other projects related to pain management and local targeted therapy in collaboration with Upex-Med, a biomedical company in Korea.
Generated from the website